Westpac Banking Corp Amgen Inc Transaction History

Westpac Banking Corp

  • $1.49 Trillion
  • Q3 2024

A detailed history of Westpac Banking Corp transactions in Amgen Inc stock. As of the latest transaction made, Westpac Banking Corp holds 29,363 shares of AMGN stock, worth $7.99 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
29,363
Previous 27,990 4.91%
Holding current value
$7.99 Million
Previous $8.75 Billion 8.18%
% of portfolio
0.63%
Previous 0.69%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$309.38 - $337.38 $424,778 - $463,222
1,373 Added 4.91%
29,363 $9.46 Billion
Q2 2024

Aug 14, 2024
BUY
$262.75 - $319.31 $7.19 Million - $8.74 Million
27,366 Added 4385.58%
27,990 $8.75 Billion
Q2 2024

Aug 12, 2024
SELL
$262.75 - $319.31 $7.16 Million - $8.7 Million
-27,239 Reduced 97.76%
624 $8.75 Billion
Q1 2024

May 09, 2024
SELL
$268.87 - $324.56 $256,770 - $309,954
-955 Reduced 3.31%
27,863 $7.92 Billion
Q4 2023

Feb 08, 2024
SELL
$255.7 - $288.46 $730,279 - $823,841
-2,856 Reduced 9.02%
28,818 $8.3 Billion
Q3 2023

Nov 09, 2023
BUY
$218.65 - $271.46 $1.16 Million - $1.43 Million
5,284 Added 20.02%
31,674 $8.51 Billion
Q2 2023

Aug 10, 2023
SELL
$214.27 - $253.37 $15.7 Million - $18.6 Million
-73,437 Reduced 73.56%
26,390 $5.86 Billion
Q1 2023

May 03, 2023
SELL
$225.79 - $275.2 $675,563 - $823,398
-2,992 Reduced 2.91%
99,827 $24.1 Billion
Q4 2022

Feb 06, 2023
BUY
$229.03 - $291.01 $65,273 - $82,937
285 Added 0.28%
102,819 $27 Billion
Q3 2022

Nov 08, 2022
BUY
$224.46 - $253.15 $483,711 - $545,538
2,155 Added 2.15%
102,534 $23.1 Billion
Q2 2022

Aug 10, 2022
BUY
$230.71 - $256.74 $72,904 - $81,129
316 Added 0.32%
100,379 $24.4 Billion
Q1 2022

May 11, 2022
SELL
$219.27 - $242.57 $1.33 Million - $1.47 Million
-6,068 Reduced 5.72%
100,063 $24.2 Million
Q4 2021

Feb 08, 2022
SELL
$198.88 - $227.6 $653,917 - $748,348
-3,288 Reduced 3.0%
106,131 $23.9 Billion
Q3 2021

Oct 27, 2021
SELL
$212.27 - $248.7 $1.27 Million - $1.49 Million
-6,006 Reduced 5.2%
109,419 $23.3 Million
Q2 2021

Aug 11, 2021
SELL
$233.58 - $259.14 $1.13 Million - $1.26 Million
-4,856 Reduced 4.04%
115,425 $28.1 Million
Q1 2021

May 13, 2021
SELL
$221.91 - $258.6 $599,157 - $698,220
-2,700 Reduced 2.2%
120,281 $29.9 Million
Q4 2020

Feb 11, 2021
BUY
$216.38 - $257.67 $6.19 Million - $7.37 Million
28,608 Added 30.31%
122,981 $28.3 Million
Q3 2020

Nov 10, 2020
BUY
$234.65 - $260.95 $236,996 - $263,559
1,010 Added 1.08%
94,373 $24 Million
Q2 2020

Aug 12, 2020
SELL
$197.81 - $242.74 $1.27 Million - $1.56 Million
-6,432 Reduced 6.45%
93,363 $22 Million
Q1 2020

May 14, 2020
SELL
$182.24 - $241.7 $726,226 - $963,174
-3,985 Reduced 3.84%
99,795 $20.2 Million
Q4 2019

Feb 11, 2020
SELL
$189.21 - $243.2 $492,892 - $633,536
-2,605 Reduced 2.45%
103,780 $25 Million
Q3 2019

Nov 13, 2019
SELL
$174.11 - $208.62 $17,411 - $20,862
-100 Reduced 0.09%
106,385 $20.6 Million
Q2 2019

Aug 01, 2019
BUY
$166.7 - $195.41 $580,782 - $680,808
3,484 Added 3.38%
106,485 $0
Q1 2019

May 14, 2019
BUY
$180.87 - $203.88 $2.08 Million - $2.34 Million
11,491 Added 12.56%
103,001 $0
Q3 2018

Nov 13, 2018
SELL
$185.29 - $208.89 $430,984 - $485,878
-2,326 Reduced 2.48%
91,510 $0
Q1 2018

May 01, 2018
BUY
$169.43 - $198.0 $937,456 - $1.1 Million
5,533 Added 6.27%
93,836 $0
Q4 2017

Jan 18, 2018
BUY
$168.79 - $188.59 $1.24 Million - $1.39 Million
7,363 Added 9.1%
88,303 $0
Q3 2017

Oct 30, 2017
BUY
$167.29 - $191.0 $13.5 Million - $15.5 Million
80,940
80,940 $0

Others Institutions Holding AMGN

# of Institutions
3,097
Shares Held
406M
Call Options Held
7.56M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email